John Neylan

John Neylan

Technik-/Wissenschafts-/F&E-Leiter bei AKARI THERAPEUTICS, PLC
72 Jahre
Health Technology
Consumer Services
Commercial Services

Profil

John F.
Neylan
is Chief Medical Officer & Executive Vice President at Akari Therapeutics Plc since 2022.
Formerly, Dr. Neylan was Chief Medical Officer & Senior Vice President at Angion Biomedica Corp.
from 2018 to 2022, Chief Medical Officer & Senior Vice President at Keryx Biopharmaceuticals, Inc. from 2015 to 2018, Vice President-Research & Development at Wyeth Research from 2000 to 2008, Director at Advances In Kidney Disease & Health, Senior Vice President-Clinical Development at Genzyme Corp., Professor at Emory University, Assistant Professor at the University of California, Davis, and President of The American Society of Transplantation.
Education includes undergraduate studies at Duke University and a doctorate from Rush Medical College.

Aktive Positionen von John Neylan

UnternehmenPositionBeginn
AKARI THERAPEUTICS, PLC Technik-/Wissenschafts-/F&E-Leiter 08.11.2022

Ehemalige bekannte Positionen von John Neylan

UnternehmenPositionEnde
ANGN BIOM Technik-/Wissenschafts-/F&E-Leiter 15.08.2022
KERYX BIOPHARMACEUTICALS Technik-/Wissenschafts-/F&E-Leiter 12.12.2018
Corporate Officer/Principal 01.05.2008
Direktor/Vorstandsmitglied -
Präsident -
Sehen Sie sich die Erfahrung von John Neylan im Detail an

Ausbildung von John Neylan

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

54

Beziehungen ersten Grades

11

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen11

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Commercial Services

Consumer Services

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. John Neylan